Findings from Can-Fite's Phase II Liver Cancer Study were Presented at ASCO Annual Meeting Late-Breaking Session | Business Wire
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Can-Fite to Treat Advanced Liver Cancer Patients with Namodenoson Under Compassionate Use Setting in Israel | Business Wire
Ribociclib Improves Progression-Free Survival for Women with Metastatic Breast Cancer
Collaterals
Transnational cancer research lab | Felsenstein Medical Research Center
PLOS ONE: Bisphosphonates in the Adjuvant Setting of Breast Cancer Therapy—Effect on Survival: A Systematic Review and Meta-Analysis
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
PLOS ONE: Factors Affecting Communication Patterns between Oncology Staff and Family Members of Deceased Patients: A Cross-Sectional Study
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy | npj Breast Cancer
Prof.Salomon Stemmer
GRAPES: A CANCER CELL INHIBITOR?
New Long-Term Outcomes Data Reconfirm Value of Oncotype DX Breast Recurrence Score® Test to Target Chemotherapy | WebMagspace
肿瘤专家团队- 垒登健康科技
OncologyEducation on Twitter: "Dr. Salomon Stemmer provides an update of Namodenoson in patients with Child-Pugh B hepatocellular carcinoma in this video from #ASCO19: https://t.co/82i6FiEBcN… https://t.co/3aAVqpqbMy"
Faculty | CoBrCa – Controversies in Breast Cancer
Transnational cancer research lab | Felsenstein Medical Research Center
Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry – ScienceOpen
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Oncology Education | Videos
Congratulations to Dr. Prasanna Alluri,... - UT Southwestern Radiation Oncology | Facebook
GRAPES: A CANCER CELL INHIBITOR?
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology
Doxorubicin-induced ovarian toxicity – topic of research paper in Veterinary science. Download scholarly article PDF and read for free on CyberLeninka open science hub.
